BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Business

  Dynavax Technologies Corporation and GlaxoSmithKline Expand Their Worldwide Strategic Alliance to Up to $203 Million

  October 21, 2011

   · 

  3 min read
• Drug Development

  Merck & Co., Inc. Says Victrelis Working in HIV Patients, Reports Phase 2 Results

  October 21, 2011

   · 

  12 min read
• Amsterdam Molecular Therapeutics (AMT) Receives Opinion on Re-examination of Glybera(R) Marketing Authorisation Application

  October 21, 2011

   · 

  4 min read
• BioMidwest

  Women’s Health Devicemaker CerviLenz Inc. Ups Series A to $8.35 Million

  October 21, 2011

   · 

  1 min read
• Genetown

  AMAG Pharmaceuticals, Inc. to Host Conference Call on October 21, 2011 at 10:00 a.m. ET to Discuss the Results of the Special Meeting of Stockholders Vote

  October 21, 2011

   · 

  1 min read
• Business

  Dermira Scores $42 Million Series A Financing to Fund Therapeutic Advances in Dermatology

  October 21, 2011

   · 

  3 min read
• Business

  Teleflex Incorporated Signs Definitive Agreement to Sell Aerospace Businesses for $280 Million

  October 21, 2011

   · 

  2 min read
• Job Trends

  Cadence Adds 20 Jobs in Virginia

  October 21, 2011

   · 

  1 min read
• Policy

  Greene LLP Announces $14.5 Million Settlement with Pfizer Inc. in False Claims Act Case Alleging Off-Label Promotion of Detrol

  October 21, 2011

   · 

  2 min read
• Merck KGaA to Return Safinamide Rights to Newron Pharmaceuticals, Citing “Limited Market Potential”

  October 21, 2011

   · 

  5 min read